Metabolomics reveals early predictors of blastocyst formation in equine ICSI-derived embryos.

Overview

• This research explores how metabolomic analysis of culture media can identify early metabolic markers that predict which equine embryos produced by ICSI will successfully develop into blastocysts.
• It aims to provide a non-invasive method for early embryo viability assessment to improve embryo selection and outcomes in horse breeding programs.

Background and Significance

• Equine in vitro embryo production (IVP) combining ovum pick-up (OPU) and intracytoplasmic sperm injection (ICSI) is increasingly used, especially in sport-horse breeding, because it allows year-round embryo production and use of valuable or fertility-challenged mares.
• Current methods to assess embryo viability rely heavily on morphological evaluation, which is subjective and limited, particularly at early developmental stages.
• Non-invasive metabolomic profiling of embryo culture media offers a promising alternative approach to accurately assess the metabolic activity and viability of embryos without harming them.

Study Objective

• The study aimed to compare the metabolomic profiles of culture media from Day 4 equine embryos produced by ICSI, distinguishing those that continue developing to blastocyst stage (viable) from those arrested at morula stage (non-viable).
• The researchers hypothesized that metabolic signatures measured in the culture medium could serve as early biomarkers of developmental competence.

Methods

• Equine embryos were individually cultured, and culture media samples were collected on Day 4 post-ICSI.
• Metabolites in the media were analyzed using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) to identify and quantify amino acids, lipids, and other metabolites.
• The metabolic consumption or secretion patterns of viable versus non-viable embryos were compared statistically.

Key Findings

• Viable Day 4 embryos exhibited significantly higher consumption of dihydroxyphenylalanine (DOPA) compared to non-viable ones, indicating its potential role as an early predictor.
• Several metabolites were secreted in greater amounts by viable embryos, including:
  • Amino acid derivatives such as hippuric acid, glutamate, and homoarginine.
  • Glycerolipids like diglycerides (DG 18:0_20:0) and triglycerides (TG 17:0_36:4).
  • Phosphatidylcholines (PC O-34:3, PC O-36:3).
  • Cholesteryl ester (CE 22:2).
  • Ceramides including Hex2Cer d18:1/24:1, Hex2Cer d18:1/20:0, and Cer d16:1/23:0.
  • Dehydroepiandrosterone sulfate (DHEAS) and glycodeoxycholic acid (GDCA).
• The distinct metabolic profiles demonstrated a link between specific lipid and amino acid metabolism pathways and embryo developmental potential.

Implications

• The study suggests that metabolomic profiling of culture media can serve as a non-invasive, early biomarker-based assay to predict embryo viability as early as Day 4 of development.
• Early identification of viable embryos could:
  • Enable earlier and more accurate embryo selection for transfer or cryopreservation (vitrification).
  • Shorten culture periods, potentially improving the efficiency and outcomes of assisted reproductive technologies (ART) in horses.
  • Reduce reliance on subjective morphological assessments.
• This is among the first comprehensive metabolomic studies on equine ICSI embryos, laying groundwork for applying metabolomics in equine ART protocols.

Conclusion

• The research identifies specific metabolic markers in the culture media of equine ICSI embryos that are associated with continued development to the blastocyst stage.
• These findings open pathways to develop reliable, non-invasive tests for embryo viability that could enhance success rates and streamline breeding programs in the equine industry.